Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

343 results about "Skin penetration" patented technology

Skin penetration can be defined as a procedure where the skin is cut, torn, punctured, shaved or penetrated in any way.

NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery

The invention describes novel formulations of nonsteroidal anti-inflammatory drugs (NSAIDs) based on complex aggregates with at least three amphipatic components suspended in a suitable, e.g. pharmaceutically acceptable, polar liquid medium. A suitably ionised NSAID is one of the two, amongst said three, components that tends to destabilise lipid membranes, the other system component with such activity being typically a surfactant. In contrast, the remaining amongst said at least three amphipatic components typically forms a stable lipid membrane on it's own. An essential characteristics of the resulting, relatively large, aggregates is an improved ability to penetrate pores, in a semi-permeable barrier, at least 30%, and often much smaller than the average diameter of the complex aggregate. This enables said aggregates to mediate NSAID transport through semi-permeable barriers including mammalian skin. As a result of the skin penetration by NSAID loaded large aggregates, the drug delivered transcutaneously with such carriers gets deeper into the tissue than the corresponding NSAID from a solution on the skin surface. This is believed to be due to the special ability of suitable large carriers to bypass the local sink of blood capillaries at the epidermal-dermal junction in the skin. The carrier-mediated delivery of locally applied NSAIDs thus allows therapy of deep tissues under the drug administration site, which is medically highly desirable.
Owner:IDEA AG

Skin Permeation Device for Analyte Sensing or Transdermal Drug Delivery

Devices, systems, kits and methods for increasing the skin's permeability controlled by measured skin electrical parameter are described herein. They may be used for transdermal drug delivery and / or analyte extraction or measurement. The controlled abrasion device contains (i) a hand piece, (ii) an abrasive tip, (iii) a feedback control mechanism, (iv) two or more electrodes, and (v) an electrical motor. Preferably the feedback control mechanism is an internal feedback control mechanism. In this embodiment, the abrasive tip contains two electrodes, i.e. both the source electrode and the return electrode. In another embodiment, the feedback control mechanism is an external feedback control. In the preferred embodiment for external feedback control, the device contains a co-axial or concentric arrangement of the two electrodes. In this embodiment, the abrasive tip contains the source electrode and the return electrode is located at the proximal end of the hand piece. The abrasive tip can be made of any material with a surface that can abrade skin. The material can be conductive or non-conductive. The controlled abrasion device may be provided in a kit, where the kit contains the device, one or more abrasive tips, optionally with a wetting fluid. The method for increasing the skin's permeability requires applying the controlled abrasion device to a portion of the skin's surface for a short period of time. The desired level of skin impedance, and thus the resulting permeability of the treated site, can be set at a predetermined value. Alternatively, the level of skin impedance can be selected based on the desired level of skin integrity, the subject's sensation of discomfort, or the duration of the application. The device contains a control mechanism which uses an appropriate algorithm or signal processing on the conductivity information provided by the electrodes to determine when the desired level of skin permeability has been reached. Once the desired level has been reached, the abrasion device is removed and either a drug delivery composition or device or an analyte sensor is applied to the treated site.
Owner:ECHO THERAPEUTICS INC

Manufacturing method for healthcare pillow pillowcase cloth

The invention relates to a manufacturing method for healthcare pillow pillowcase cloth. The manufacturing method is characterized by including: weaving grey cloth, and adding, by weight, 800-920 parts of water, 15-25 parts of chrysanthemum, 10-20 parts of prepared Sichuan aconite root, 5-15 parts of root of angelica dahurica, 5-15 parts of kudzuvine root, 10-20 parts of Szechuan lovage rhizome, 6-12 parts of root of red-rooted salvia and 8-16 parts of ageratum into a pressure vessel for heating at the temperature ranging from 45 DEG C to 49 DEG C prior to heat preservation for 230-270 minutes; performing final treatment. Various traditional Chinese medicine compositions of natural Chinese herbal medicine for socking a pillowcase are mixed together, so that various medical effects are multiplied and work together, for example, the chrysanthemum has the effect of dispelling wind and clearing heat and improving eyesight and detoxifying; the prepared Sichuan aconite root has the effect of dispelling wind-cold, scattering wind-evil and warming menstruation and relieving pain; the root of angelica dahurica has the effect of relieving swelling and pain and treating neurasthenia headache; the kudzuvine root has the effect of generating Yang and relaxing muscles, relieving restlessness and quenching thirst and treating high blood pressure; the Szechuan lovage rhizome has the effect of promoting circulation of Qi and relieving depression and promoting blood circulation to arrest pain. The effective components of the medicine enter a human body by means of skin penetration, acupuncture point absorption, meridian transmission and the like.
Owner:HUZHOU JINTADI TEXTILE MILL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products